Astrana Health Inc. (ASTH)
NASDAQ: ASTHConsumer DiscretionaryProfessional ServicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 37.14 0.00%
ASTH stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.84B
- P/E (TTM)
- 44.75
- Forward P/E
- 10.21
- EPS (TTM)
- $0.83
- Dividend yield
- None
- 52-week range
- 18.08 – 51.60
- Day range
- 36.65 – 37.66
- Volume / Avg
- 664.49K / 459.62K
- Beta
- —
- Shares outstanding
- 49.60M
- Next earnings
- Nov 5, 2026
52-week range
ASTH stock today
Shares of Astrana Health (ASTH) finished higher on Oct 7 at $37.14, a gain of 0.38% or $0.14 per share, versus the S&P 500's 0.22% decline. At this level, ASTH sits in the middle of its 52-week range of $18.08 to $51.60: 28.0% below the high, set on Jul 2, 2026 and 105.4% above the low. ASTH is up 49.7% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 22.5%.
At 44.7x trailing earnings, Astrana Health trades above the peer-group median of 20.8x. Its forward P/E of 10.2x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Astrana Health's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Astrana Health
Company profileAstrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
- Sector
- Consumer Discretionary
- Industry
- Professional Services
- CEO
- Mr. Brandon K. Sim M.S.
- Headquarters
- Alhambra, CA
- Employees
- 3,000
- Website
- astranahealth.com
Analyst forecast
ForecastConsensus (10 analysts)
strong_buy
Avg. price target
$51.67+39.12%
- Strong buy 2
- Buy 7
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $0.44
Astrana Health peers
Consumer Discretionary sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NSPInsperity Inc. | 48.23 | +3.90% | $1.84B | vs ASTH |
| ICFIICF International Inc. | 82.85 | -0.29% | $1.49B | vs ASTH |
| EFOREverforth Inc. | 34.91 | -2.95% | $1.43B | vs ASTH |
| AMNAMN Healthcare Services Inc | 36.53 | -0.54% | $1.41B | vs ASTH |
| MANManpowerGroup | 52.87 | +1.93% | $2.46B | vs ASTH |
| HURNHuron Consulting Group Inc. | 156.61 | -0.41% | $2.49B | vs ASTH |
| KFRCKforce Inc. | 51.74 | +2.09% | $926.61M | vs ASTH |
| KELYBKelly Services Inc. Class B | 22.19 | -0.94% | $770.70M | vs ASTH |
Indexes, lists and sector
Largest Consumer Discretionary stocks
Astrana Health stock FAQ
What is Astrana Health's stock price today?
ASTH last traded at $37.14 as of Oct 7, 4:00 PM EDT, up 0.38% on the day. Prices are delayed at least 15 minutes.
Does Astrana Health pay a dividend?
No. Astrana Health does not currently pay a regular cash dividend.
When is Astrana Health's next earnings date?
Astrana Health is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $0.44.
What is ASTH's P/E ratio?
ASTH trades at a trailing P/E ratio of 44.75 and a forward P/E of 10.21, compared with a median of 20.8 for its closest peers.
Who is Astrana Health's CEO?
Mr. Brandon K. Sim M.S. is the chief executive officer of Astrana Health Inc., which has about 3,000 employees.
Has ASTH ever split its stock?
Yes. The most recent ASTH stock split was a 1-for-10 split on Apr 27, 2015.
What is the ASTH 52-week high?
The 52-week high for ASTH is $51.60 and the 52-week low is $18.08. The stock is currently 28.0% below its high.